Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Rank in Stocks #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Share Price
$0.01142111
Last synced: 2025-03-21
Market Cap
$930.66K
Change (1 day)
0.18%
Change (1 year)
-69.73%
Country
IE
Trade Ovoca Bio plc (OVXA)

Category

Earnings for Ovoca Bio plc (OVXA)
Earnings in Jun 2024 TTM: $-5.54M
According to Ovoca Bio plc latest financial reports the company's current earnings are $-5.54M. In 2023 the company made an earning of $-5.64M, an increase over its 2022 earnings that were of $-6.02M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Ovoca Bio plc from 2001 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -95,296.05%
US
$1.95B -35,303.36%
NL
$-3.09B 55,611.05%
US
$-4.02B 72,380.25%
AU
- -
CH